Cart
sales@molnova.com
Bipenquinate
CAS No. 96201-88-6
Bipenquinate( —— )
Catalog No. M22085 CAS No. 96201-88-6
Bipenquinate is a potent and selective inhibitor of dihydroorotate dehydrogenase (DHODH) with IC50 of 20 nM,?blocking de novo pyrimidine biosynthesis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 86 | In Stock |
|
| 5MG | 129 | In Stock |
|
| 10MG | 210 | In Stock |
|
| 25MG | 389 | In Stock |
|
| 50MG | 505 | In Stock |
|
| 100MG | 710 | In Stock |
|
| 500MG | 1494 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBipenquinate
-
NoteResearch use only, not for human use.
-
Brief DescriptionBipenquinate is a potent and selective inhibitor of dihydroorotate dehydrogenase (DHODH) with IC50 of 20 nM,?blocking de novo pyrimidine biosynthesis.
-
DescriptionBipenquinate is a potent and selective inhibitor of dihydroorotate dehydrogenase (DHODH) with IC50 of 20 nM,?blocking de novo pyrimidine biosynthesis.
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetDehydrogenase
-
RecptorDHODH
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number96201-88-6
-
Formula Weight397.36
-
Molecular FormulaC23H14F2NNaO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[Na+].Cc1c(nc2ccc(F)cc2c1C([O-])=O)-c1ccc(cc1)-c1ccccc1F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Li S F , Gong M J , Sun Y F , et al. Antiviral activity of brequinar against foot-and-mouth disease virus infection in vitro and in vivo[J]. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, 116:108982.
molnova catalog
related products
-
Glomeratose A
Glomeratose A is a lactate dehydrogenase inhibitor.
-
3-(IMIDAZOL-4-YL)PRO...
3-(IMIDAZOL-4-YL)PROPIONIC ACID is a product of histidine metabolism and may involve oxidation or transamination.
-
AG-120 (racemic)
AG-120 (racemic), the racemic mixture of AG-120, is an orally available isocitrate dehydrogenase type 1 (IDH1) inhibitor, and shows potential antineoplastic activity.
